Article: Tissue processing company revises second quarter results.(CryoLife Inc. )

2002 OCT 27 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY), a life-science company involved in the development and commercialization of cryopreserved and manufactured implantable tissues and surgical adhesives, reported that it filed its 10-Q for the quarter ended June 30, 2002.

The document is certified by the company's CEO and CFO.

CryoLife revised its previously announced 2002 second quarter results due to the U.S. Food and Drug Administration order it received on August 13, 2002, which ordered non-valved cardiac, vascular, and orthopedic tissue processed since October 3, 2001, by CryoLife to be retained "until it is recalled, destroyed, the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!